These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15006311)

  • 1. FFPRHC Guidance (January 2004). The copper intrauterine device as long-term contraception.
    Penney G; Brechin S; de Souza A; Bankowska U; Belfield T; Gormley M; Olliver M; Hampton N; Howlett-Shipley R; Hughes S; Mack N; O'Brien P; Rowlands S; Trewinnard K;
    J Fam Plann Reprod Health Care; 2004 Jan; 30(1):29-41; quiz 42. PubMed ID: 15006311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FFPRHC Guidance (October 2003): First prescription of combined oral contraception.
    Faculty of Family Planning and Reproductive Health Care, Clinical Effectiveness Unit
    J Fam Plann Reprod Health Care; 2003 Oct; 29(4):209-22. PubMed ID: 14662054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FFPRHC Guidance (July 2005): The use of contraception outside the terms of the product licence.
    Penney G; Brechin S; Allerton L;
    J Fam Plann Reprod Health Care; 2005 Jul; 31(3):225-41; quiz 242. PubMed ID: 16105289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FFPRHC Guidance: emergency contraception (April 2003).
    Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit
    J Fam Plann Reprod Health Care; 2003 Apr; 29(2):9-16. PubMed ID: 12681030
    [No Abstract]   [Full Text] [Related]  

  • 6. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FFPRHC Guidance (April 2004). The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health.
    Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit
    J Fam Plann Reprod Health Care; 2004 Apr; 30(2):99-108; quiz 109. PubMed ID: 15086994
    [No Abstract]   [Full Text] [Related]  

  • 8. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of IUDs in developing countries: a comparative study.
    Farr G; Burdan A
    Netw Res Triangle Park N C; 1991 Sep; 12(2):6-8, 12. PubMed ID: 12284280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of use of intrauterine devices among HIV-1-infected women.
    Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
    Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modern intra-uterine devices.
    Odlind V
    Baillieres Clin Obstet Gynaecol; 1996 Apr; 10(1):55-67. PubMed ID: 8736722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
    Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.
    Sivin I; Stern J; Coutinho E; Mattos CE; el Mahgoub S; Diaz S; Pavez M; Alvarez F; Brache V; Thevenin F
    Contraception; 1991 Nov; 44(5):473-80. PubMed ID: 1797462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability of IUDs is increasing.
    Finger WR; Barr D
    Netw Res Triangle Park N C; 1992 Oct; 13(2):27-30. PubMed ID: 12286082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended use of the intrauterine device: a literature review and recommendations for clinical practice.
    Wu JP; Pickle S
    Contraception; 2014 Jun; 89(6):495-503. PubMed ID: 24679478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FFPRHC Guidance (April 2006). Emergency contraception.
    Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit
    J Fam Plann Reprod Health Care; 2006 Apr; 32(2):121-8; quiz 128. PubMed ID: 16824309
    [No Abstract]   [Full Text] [Related]  

  • 17. Faculty statement from the CEU on a new publication: WHO Selected Practice Recommendations for Contraceptive Use Update. Missed pills: new recommendations.
    Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit
    J Fam Plann Reprod Health Care; 2005 Apr; 31(2):153-5. PubMed ID: 15921560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
    Eggebroten JL; Sanders JN; Turok DK
    Am J Obstet Gynecol; 2017 Jul; 217(1):51.e1-51.e7. PubMed ID: 28342716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of actinomyces-like organisms in Papanicolaou-stained smears of copper- and levonorgestrel-releasing intrauterine devices.
    Merki-Feld GS; Lebeda E; Hogg B; Keller PJ
    Contraception; 2000 Jun; 61(6):365-8. PubMed ID: 10958879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.